about
Fractional exhaled nitric oxide-measuring devices: technology update.Nitric-oxide synthase 2 interacts with CD74 and inhibits its cleavage by caspase during dendritic cell developmentUsing magnetic resonance imaging to quantify the inflammatory response following allergen challenge in allergic rhinitisExhaled nitric oxide in asthma: progress since the introduction of standardized methodology.Reduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markers.Chronic rhinosinusitis pathogenesis.Mouse nasal epithelial innate immune responses to Pseudomonas aeruginosa quorum-sensing molecules require taste signaling components.Bitter and sweet taste receptors in the respiratory epithelium in health and diseaseMeasurements of fractional exhaled nitric oxide in pediatric asthma.Nitric oxide production is stimulated by bitter taste receptors ubiquitously expressed in the sinonasal cavity.Nitric oxide: a promising methodological approach in airway diseases.Effects of atopy and rhinitis on exhaled nitric oxide values - a systematic review.Primary ciliary dyskinesia, an orphan disease.Clinical application of exhaled nitric oxide measurement in pediatric lung diseases.Exhaled nasal nitric oxide during humming: potential clinical tool in sinonasal disease?Clinical application of nasal nitric oxide measurement in pediatric airway diseases.Role of the bitter taste receptor T2R38 in upper respiratory infection and chronic rhinosinusitis.Taste receptors in innate immunityFlavones modulate respiratory epithelial innate immunity: Anti-inflammatory effects and activation of the T2R14 receptor.The genetics of the bitter taste receptor T2R38 in upper airway innate immunity and implications for chronic rhinosinusitis.New insights into upper airway innate immunity.The effects of nitric oxide on Staphylococcus aureus biofilm growth and its implications in chronic rhinosinusitis.Taste Receptors: Regulators of Sinonasal Innate Immunity.Sinonasal T2R-mediated nitric oxide production in response to Bacillus cereus.Clara cell protein in nasal lavage fluid and nasal nitric oxide - biomarkers with anti-inflammatory properties in allergic rhinitis.Effect of glucocorticoids on nasal polyposis, with detection of inflammatory response by measurement of nitric oxide levels in nasal polyp tissue.Vitamin D: emerging roles in infection and immunity.Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis.Comparison of arginase isoform expression in patients with different subtypes of chronic rhinosinusitis.Increased expression of arginase I and II in allergic nasal mucosa.Activation of airway epithelial bitter taste receptors by Pseudomonas aeruginosa quinolones modulates calcium, cyclic-AMP, and nitric oxide signaling.Chemosensory irritations and pulmonary effects of acute exposure to emissions from oriented strand board
P2860
Q26744314-E1BF7728-5BDF-4AC8-A788-9A6E9B70A506Q28505741-E9542DC3-079C-4F9A-85B3-49388B866EFFQ30394467-418B07E1-7740-4F12-AD0A-A622EFB27F2EQ34006217-BA1E3CD8-BFB4-45BC-A163-7234B8E7A1B5Q35043722-2EA33A9B-4A1F-4604-9BB6-F8E56B30C83BQ35865515-267470DF-FC0A-49A2-ABBE-4A44F77C7239Q36738556-787E4631-ACB8-4A7A-8832-73CDD1654335Q36795267-3106BB5B-D096-40CB-8827-2FF5A5DBC621Q37306913-B0015EB4-7F3D-46D1-B839-0CFDEEE37DEFQ37708211-F3A00A24-9536-4438-9741-3C6A94D9E7AAQ37914641-CC1F2A5B-14DF-4C0D-95EC-0D4AE844A773Q37992721-DA494877-D340-4996-983F-F7883C9E95E5Q38025037-A480C14B-2E32-4694-814C-51B2ABBA4823Q38070209-FC363D8C-B67C-40EE-B817-B60FB48CCD35Q38095107-CDC712ED-CACD-45ED-A4DB-2511F591BF5FQ38243301-ACA627B5-1F98-4910-B6F6-B9533A48C232Q38258989-95D48A89-3C71-44CE-B428-BA96F9258E2CQ38260860-3D3409F8-243D-4F6E-907F-60F53D5CA322Q38857622-58660335-2795-4E1F-8655-323B7906D5ADQ38960116-48D74A49-7643-4B58-997D-7A9B3C750129Q38961660-FFA0F5D4-5379-4763-855D-D32AAD9212F5Q39678932-40E95F92-A1CD-459D-9F70-4C50FF5ECB04Q40461697-9CB388ED-F238-4DB1-8819-2CE4E684CC8DQ40958310-9BA045D7-656E-4E46-977B-E5DBDDE42534Q41888915-74BF31B3-B7E7-4DEC-A148-8C466DF5D0F8Q44043522-86C55401-9E81-46ED-B9BE-9515417213D3Q44132017-F6D4CDC5-0916-4B1E-8ECC-3B1852D2F0C7Q46108631-DA9699ED-0B28-4C34-8BC2-7CBA10352F9BQ51581850-7CF7F054-F3B1-44FC-A5D7-557203A0C1CEQ54390718-E222B786-083D-412B-8EC9-6A93876E5436Q54979349-CAAFB0CC-8F67-4940-A829-856131F4B5B1Q57112812-BB992B65-417D-4798-B713-655D179E7498
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Nitric oxide in upper airways inflammatory diseases.
@ast
Nitric oxide in upper airways inflammatory diseases.
@en
type
label
Nitric oxide in upper airways inflammatory diseases.
@ast
Nitric oxide in upper airways inflammatory diseases.
@en
prefLabel
Nitric oxide in upper airways inflammatory diseases.
@ast
Nitric oxide in upper airways inflammatory diseases.
@en
P2093
P1476
Nitric oxide in upper airways inflammatory diseases.
@en
P2093
P2888
P356
10.1007/S00011-006-6111-1
P577
2007-02-01T00:00:00Z